The association and predictive value analysis of metabolic syndrome on diastolic heart failure in patients at high risk for coronary artery disease

Table 2 Univariate regression analysis for diastolic heart failure

Variables	β	S.E.	P value	OR	95.0% C.I.
BMI	0.60	0.27	0.03	1.82	1.06-3.14
SBP	0.05	0.01	<0.001	1.06	1.04-1.08
DBP	0.03	0.01	0.003	1.03	1.01-1.06
FPG	0.83	0.50	0.010	2.29	1.85-6.17
TG	0.69	0.28	0.014	2.00	1.15-3.47
HDL	−0.47	0.43	0.269	0.62	0.27-1.45
MetS	0.78	0.13	<0.001	2.20	1.70-2.84
Age	0.86	0.11	<0.001	2.36	1.87-2.99
Ccr	−0.02	0.01	<0.001	0.97	0.97-0.98
Cr	0.02	0.01	<0.001	1.02	1.01-1.04
UA	1.38	0.37	<0.001	4.00	1.94-8.26
LVMI	0.02	0.01	<0.001	1.02	1.02-1.03
HT	2.03	0.28	<0.001	7.66	4.36-13.48
DM	1.01	0.26	<0.001	2.73	1.65-4.55
CAD	1.02	0.28	<0.001	2.78	1.58-4.90

Note: MI Body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, MetS metabolic syndrome, HT Hypertension, DM Diabetes, FPG fasting plasma glucose, PBG plasma blood glucose, HbA1c glycated hemoglobin, TC serum total cholesterol, HDL high-density lipoprotein cholesterol, TG triglyceride, UA uric acid, LDL low density lipoprotein cholesterol, Ccr creatinine clearance rate, Cr creatinine, LVMI left ventricular mass index, LAD left atrial diameter, DT deceleration time, LVEF left ventricular ejection fraction.

ISSN: 1758-5996